Identification of a Novel Ras-Regulated Proapoptotic Pathway
暂无分享,去创建一个
R. Xavier | B. Seed | J. Avruch | S. Rabizadeh | A. Khokhlatchev | Tao Chen | Xian-feng Zhang | M. Nedwidek
[1] J. Avruch,et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1 , 2002, Oncogene.
[2] A. Protopopov,et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] E. Krebs,et al. Both Phosphorylation and Caspase-mediated Cleavage Contribute to Regulation of the Ste20-like Protein Kinase Mst1 during CD95/Fas-induced Apoptosis* , 2001, The Journal of Biological Chemistry.
[4] J. Minna,et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.
[5] Norinobu M. Watanabe,et al. The Ste20 group kinases as regulators of MAP kinase cascades. , 2001, Trends in cell biology.
[6] G. Yang,et al. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. , 2001, Cancer research.
[7] X. F. Zhang,et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.
[8] D. Bredesen,et al. An alternative, nonapoptotic form of programmed cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] D. Faller,et al. Oncogenic Ras Mediates Apoptosis in Response to Protein Kinase C Inhibition through the Generation of Reactive Oxygen Species* , 2000, The Journal of Biological Chemistry.
[10] A. Bell,et al. Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis* , 2000, The Journal of Biological Chemistry.
[11] J. Minna,et al. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. , 2000, Cancer research.
[12] C. Reutelingsperger,et al. Flow cytometry of apoptotic cell death. , 2000, Journal of immunological methods.
[13] H. Sheng,et al. Oncogenic Ras-mediated Cell Growth Arrest and Apoptosis are Associated with Increased Ubiquitin-dependent Cyclin D1 Degradation* , 2000, The Journal of Biological Chemistry.
[14] G. Clark,et al. The importance of being K-Ras. , 2000, Cellular signalling.
[15] Chun Xing Li,et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 , 2000, Nature Genetics.
[16] C. Der,et al. Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.
[17] S. Chandra,et al. A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor , 2000, Nature Medicine.
[18] A. Balmain,et al. Integration of positive and negative growth signals during ras pathway activation in vivo. , 2000, Current opinion in genetics & development.
[19] C. Der,et al. Analysis of function and regulation of proteins that mediate signal transduction by use of lipid-modified plasma membrane-targeting sequences. , 2000, Methods in enzymology.
[20] S. Chandra,et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. , 2000, Nature medicine.
[21] J. Minna,et al. The 630-kb Lung Cancer Homozygous Deletion Region on Human Chromosome 3 p 21 . 3 : Identification and Evaluation of the Resident Candidate Tumor Suppressor Genes 1 , 2000 .
[22] S. Rabizadeh,et al. Neurotrophin dependence mediated by p75NTR: contrast between rescue by BDNF and NGF , 1999, Cell Death and Differentiation.
[23] D. Bar-Sagi,et al. Suppression of Ras-Induced Apoptosis by the Rac GTPase , 1999, Molecular and Cellular Biology.
[24] R. Klemke,et al. Four Human Ras Homologs Differ in Their Abilities to Activate Raf-1, Induce Transformation, and Stimulate Cell Motility* , 1999, The Journal of Biological Chemistry.
[25] R. Wolthuis,et al. Ras caught in another affair: the exchange factors for Ral. , 1999, Current opinion in genetics & development.
[26] J. Hancock,et al. Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase* , 1998, The Journal of Biological Chemistry.
[27] Karen H. Vousden,et al. p14ARF links the tumour suppressors RB and p53 , 1998, Nature.
[28] M. Serrano,et al. p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.
[29] E. Nishida,et al. Proteolytic activation of MST/Krs, STE20-related protein kinase, by caspase during apoptosis , 1998, Oncogene.
[30] E. Krebs,et al. Caspase‐mediated activation and induction of apoptosis by the mammalian Ste20‐like kinase Mst1 , 1998, The EMBO journal.
[31] J. Avruch,et al. Identification of Nore1 as a Potential Ras Effector* , 1998, The Journal of Biological Chemistry.
[32] A. Lloyd. Ras versus cyclin-dependent kinase inhibitors. , 1998, Current opinion in genetics & development.
[33] C. Y. Wang,et al. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.
[34] C. Martínez-A,et al. Ras activation leads to cell proliferation or apoptotic cell death upon interleukin‐2 stimulation or lymphokine deprivation, respectively , 1997, European journal of immunology.
[35] S. Eliason,et al. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. , 1997, Journal of immunology.
[36] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[37] G. V. Vande Woude,et al. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability , 1997, Molecular and cellular biology.
[38] D. Shalloway,et al. Cell cycle-dependent activation of Ras , 1996, Current Biology.
[39] R. Erikson,et al. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. McConkey,et al. Ras signaling in tumor necrosis factor‐induced apoptosis. , 1996, The EMBO journal.
[41] S. Oldham,et al. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. Reutelingsperger,et al. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. , 1996, Cytometry.
[43] J. Downward,et al. Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation. , 1996, The EMBO journal.
[44] M. Wigler,et al. Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RAS , 1996, Science.
[45] M. Nakafuku,et al. Identification of AF-6 and Canoe as Putative Targets for Ras (*) , 1996, The Journal of Biological Chemistry.
[46] J. Chernoff,et al. Cloning and Characterization of a Human Protein Kinase with Homology to Ste20 (*) , 1995, The Journal of Biological Chemistry.
[47] J. Colicelli,et al. A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1 , 1995, Molecular and cellular biology.
[48] M. Wigler,et al. Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.
[49] L. Greene,et al. Proliferative inhibition by dominant‐negative Ras rescues naive and neuronally differentiated PC12 cells from apoptotic death. , 1994, The EMBO journal.
[50] M. Marshall,et al. The effector interactions of p21ras. , 1993, Trends in biochemical sciences.
[51] J. Walker,et al. Isolation, characterization and localization of annexin V from chicken liver. , 1993, The Biochemical journal.
[52] D. Lane,et al. ras-Induced hyperplasia occurs with mutation of p53, but activated ras and myc together can induce carcinoma without p53 mutation , 1992, Cell.
[53] E. Meyerowitz,et al. Plant genome studies: restriction fragment length polymorphism and chromosome mapping information. , 1991, Current opinion in genetics & development.
[54] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[55] M. Noble,et al. Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation. , 1988, The EMBO journal.
[56] H. Ruley,et al. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[58] R. Newbold,et al. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene , 1983, Nature.